[HTML][HTML] Predictive factors for humoral response after 2-dose SARS-CoV-2 vaccine in solid organ transplant patients
O Marion, A Del Bello, F Abravanel, S Faguer… - Transplantation …, 2022 - journals.lww.com
Background. A weak immunogenicity has been reported in solid organ transplant (SOT)
recipients after 2 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
recipients after 2 doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients
F Villanego, A Mazuecos, B Cubillo… - Clinical Kidney …, 2022 - academic.oup.com
Background Sotrovimab is a neutralizing monoclonal antibody (mAb) that seems to remain
active against recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
active against recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
Comparing the first and second wave of COVID-19 in kidney transplant recipients: an east-European perspective
FI Elec, SD Bolboacă, A Muntean, AD Elec… - European Surgical …, 2022 - karger.com
Background: The present study examined whether patient characteristics, management, and
outcome of kidney transplant recipients (KTx) with COVID-19 changed in the second versus …
outcome of kidney transplant recipients (KTx) with COVID-19 changed in the second versus …
Clinical, functional, and mental health outcomes in kidney transplant recipients 3 months after a diagnosis of COVID-19
R Duivenvoorden, P Vart, M Noordzij… - …, 2022 - journals.lww.com
Background. Kidney transplant patients are at high risk for coronavirus disease 2019
(COVID-19)–related mortality. However, limited data are available on longer-term clinical …
(COVID-19)–related mortality. However, limited data are available on longer-term clinical …
Preparing European Nephrology for the next pandemic: lessons from the ERACODA collaboration
P Vart, R Duivenvoorden, CFM Franssen… - Nephrology Dialysis …, 2023 - academic.oup.com
Owing to the vulnerability of patients with chronic kidney disease to infectious diseases, the
coronavirus disease 2019 (COVID-19) pandemic has been particularly devastating for the …
coronavirus disease 2019 (COVID-19) pandemic has been particularly devastating for the …
[HTML][HTML] COVID-19 and kidney transplantation: the impact of remdesivir on renal function and outcome-a retrospective cohort study
F Elec, J Magnusson, A Elec, A Muntean… - International Journal of …, 2022 - Elsevier
Objectives The aim of the study was to evaluate the impact of remdesivir on overall mortality,
ICU mortality, and renal functional outcome in hospitalized patients with COVID-19 who …
ICU mortality, and renal functional outcome in hospitalized patients with COVID-19 who …
[引用][C] Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients
A Mazuecos, B Cubillo, J Merino, I Poveda, IM Saura… - 2022 - Oxford University Press